Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “folic acid” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 9
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 9 pipeline programs matching "folic acid" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

9 results for “folic acid” Back to intelligence hub

Search results

  1. Iron (27 mg) - folic acid (600 ug)

    United Therapeutics Europe Ltd

    Infant Mortality

    phase 3 other completed

    1 trial
  2. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Neoplasms

    phase 3 small molecule active

    1 trial
  3. Folic Acid 5 MG

    The University of Hong Kong

    Acute Kidney Injury

    phase 1 small molecule active

    1 trial
  4. Folic Acid

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial
  5. Folic Acid

    Cardiff Oncology

    Depression

    approved small molecule completed

    1 trial
  6. Folic Acid

    Hospital Authority, Hong Kong

    Pregnant Women

    other active

    1 trial
  7. Folic Acid

    Xijing Hospital

    Stroke

    small molecule terminated

    1 trial
  8. Folic acid

    CRESCENT BIOPHARMA, INC.

    Acute Myocardial Infarction

    small molecule completed

    1 trial
  9. folic acid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Neural Tube Defects - Spina Bifida and Anencephaly

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.